J&J Wins Patent Dispute Over Birth Control Drug
A New Jersey federal judge Tuesday declared valid the patent behind Johnson & Johnson's Ortho Tri-Cyclen Lo birth control drug, blocking a Lupin Pharmaceuticals Inc. effort to market a generic competitor....To view the full article, register now.
Already a subscriber? Click here to view full article